Michelle Senchyna
Chief Tech/Sci/R&D Officer bij AERIE PHARMACEUTICALS, INC.
Profiel
Michelle Senchyna is currently the VP-Clinical Development & Medical Affairs at Aerie Pharmaceuticals, Inc. She previously worked as the Executive Director-Ophthalmology at Allergan, Inc. and as the Director-Clinical Development at PanOptica, Inc. Prior to her industry experience, she was an Assistant Professor at The University of Waterloo.
Dr. Senchyna received her undergraduate and doctorate degrees from McMaster University.
Actieve functies van Michelle Senchyna
| Bedrijven | Functie | Begin |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 03-02-2020 |
Eerdere bekende functies van Michelle Senchyna
| Bedrijven | Functie | Einde |
|---|---|---|
| ALLERGAN, INC. | Corporate Officer/Principal | - |
| The University of Waterloo | Corporate Officer/Principal | - |
PanOptica, Inc.
 PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | Corporate Officer/Principal | - |
Opleiding van Michelle Senchyna
| McMaster University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
PanOptica, Inc.
PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | Health Technology |
